Blood Propofol Measurement During Anaesthesia Using Propofol Target Controlled Infusion
Launched by UNIVERSITY HOSPITAL BIRMINGHAM NHS FOUNDATION TRUST · Mar 6, 2012
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Only patients undergoing major surgery where blood sampling through arterial or central venous catheters is part of their routine clinical care will be recruited.
- • Only patients undergoing total intravenous anaesthesia using propofol will be recruited.
- Exclusion Criteria:
- • Anaemic patients will not be recruited into the study.
- • Patients unable to consent will not be recruited into the study.
About University Hospital Birmingham Nhs Foundation Trust
The University Hospital Birmingham NHS Foundation Trust is a leading academic health institution dedicated to providing exceptional patient care, advancing medical research, and enhancing education in the healthcare field. As a prominent sponsor of clinical trials, the Trust collaborates with a network of researchers and healthcare professionals to facilitate innovative studies aimed at improving treatment outcomes and patient experiences. With a strong commitment to ethical standards and patient safety, the Trust leverages its extensive resources and expertise to drive forward clinical research initiatives that contribute to the advancement of medical science and the health of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, West Midlands, United Kingdom
Patients applied
Trial Officials
Nicholas J Cowley, MRCP FRCA
Principal Investigator
University Hospital Birmingham NHS Foundation Trust
Thomas Clutton-Brock, FRCA FRCP
Study Chair
University Hospital Birmingham NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials